查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1739315

全球自动药品亭市场

Automated Drug Kiosks
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 164 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球自动药品亭市场规模将达到 273 亿美元

全球自动贩卖机亭市场规模预计在2024年为116亿美元，预计到2030年将达到273亿美元，2024年至2030年的复合年增长率为15.3%。自动售药亭系统是本报告分析的细分市场之一，预计其复合年增长率为17.1%，到分析期结束时规模将达到196亿美元。自动售药亭服务细分市场在分析期间的复合年增长率预计为11.5%。

美国市场规模估计为 31 亿美元，中国市场预计复合年增长率为 14.3%

美国自动化药品亭市场规模预计在2024年达到31亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到42亿美元，在2024-2030年的分析期间内，复合年增长率为14.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为14.4%和13.0%。在欧洲，预计德国市场的复合年增长率为11.0%。

全球自动药品亭市场－主要趋势与驱动因素摘要

自动药品亭为何成为无障碍药局的可扩展解决方案

自动贩卖机提供了一种安全的自助服务方式，可以取代传统的药局柜檯，从而彻底改变人们的药品取得方式。这些自助售药亭可在医院、诊所、机场和偏远地区全天候提供处方药和非处方药。这简化了「最后一公里」的药品配送，同时解决了药剂师短缺和等待时间过长的难题。这些系统旨在透过电子核准和身份验证来发放预包装药品，从而提高患者便利性，同时确保合规性和存取管理。

医疗保健提供者和零售药局越来越多地部署这些自助服务终端，以扩大其覆盖范围，而无需承担扩张实体店的全部营运成本。随着远端保健的普及，自助服务终端正成为连接虚拟问诊和实体药物管理的关键接触点。与电子健康记录(EHR) 系统集成，可实现无缝的照护现场，提高用药依从性，并减少治疗开始的延误。

科技创新如何让药局亭更加安全、合规和整合？

现代自动售药亭配备了先进的安全通讯协定、生物识别和即时监控，以确保安全合规的配药。与药房管理软体和云端基础平台集成，药剂师可以远端核准处方笺、追踪库存并管理续药週期。此外，还新增了视讯会议模组，以保持患者与药剂师之间的互动，并方便药剂师按需咨询，同时保持自助售药亭的自主性。

篡改检测、温度控制和审核就绪追踪等符合监管规定的功能，使自助服务终端成为敏感和受控药物的合规解决方案。与保险资料库和电子处方笺系统的集成，可直接在自助服务终端上进行资格验证和共同支付处理。随着与更广泛的数位健康生态系统互通性的增强，这些自助服务终端正在发展成为智慧的分散式药房节点，可支援门诊病人和慢性病护理工作流程。

自动药房亭的采用在哪里加速？哪些使用案例推动了成长？

在资源受限的医疗保健系统中，尤其是在药局资源有限的农村和服务不足地区，自助取药机的应用正在加速。医院和紧急护理中心正在部署自助取药机，以便在出院后和下班后提供药物，从而降低再入院风险并提高护理的连续性。零售连锁药局正在购物中心、机场和校园等人流量大的公共场所试行自助取药机，让病患即时取得常用药物和保健产品。

政府医疗保健计画和人道主义组织正在考虑部署自助服务终端，作为偏远和低收入地区公共卫生推广工作的一部分。此外，大型雇主和大学正在其健康中心安装这些系统，以简化员工健康管理。使用案例也正在扩展到惩教机构、老年生活社区和军事基地，在这些领域，可管理、可追溯且高效的配药至关重要。

是什么推动了自动化药品亭市场的全球扩张？

市场成长的驱动力源自于医疗保健消费者意识的提升、成本控制压力以及药房服务数位转型的要求。患者日益要求便利、私密和全天候服务，而自助服务终端能够以传统配药成本的一小部分满足这些需求。疫情期间，人们转向非接触式服务模式，进一步检验了自动化配药在增强医药服务韧性和可近性方面的作用。

连锁药局、医疗系统和医疗技术公司正在携手合作，扩大部署规模，并实现与现有临床和药房工作流程的标准化整合。监管机构正在逐步更新其伙伴关係，以纳入远端药房模式，鼓励其更广泛的接受。随着医疗保健日益分散化和以患者为中心，一个核心问题日益凸显：在一个致力于提高公平性、效率和服药依从性的系统中，自动药亭能否成为「最后一哩路」药物配送的支柱？

部分

产品类型（系统、服务）；药品类型（处方笺、非处方药、其他药品类型）；最终用途（零售药局、医院/诊所、其他最终用途）

调查企业范例（共34家企业）

  • Asteres Inc.
  • Bell and Howell
  • BestKiosk
  • Capsa Healthcare
  • Diebold Nixdorf
  • Distributed Delivery Networks Corp.
  • Higi
  • Howell LLC
  • ImageHOLDERS
  • Jadak
  • MC HealthGrid Pvt Ltd.
  • MedAvail Technologies Inc.
  • MedfriendRx
  • Omnicell Inc.
  • PharmcoRx
  • PickPoint
  • Rowa Automatisierungssysteme GmbH
  • ScriptPro LLC
  • Smart RX Systems Inc.
  • Stericycle Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP33481

Global Automated Drug Kiosks Market to Reach US$27.3 Billion by 2030

The global market for Automated Drug Kiosks estimated at US$11.6 Billion in the year 2024, is expected to reach US$27.3 Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Automated Drug Kiosk Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$19.6 Billion by the end of the analysis period. Growth in the Automated Drug Kiosk Services segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 14.3% CAGR

The Automated Drug Kiosks market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.4% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Automated Drug Kiosks Market - Key Trends & Drivers Summarized

Why Are Automated Drug Kiosks Emerging as Scalable Solutions for Accessible Pharmaceutical Dispensing?

Automated drug kiosks are transforming medication access by offering secure, self-service alternatives to traditional pharmacy counters. These kiosks provide round-the-clock availability of prescription and over-the-counter drugs in hospitals, clinics, airports, and remote locations-streamlining last-mile pharmaceutical delivery while addressing pharmacist shortages and wait-time challenges. Designed to dispense pre-packaged medications via electronic authorization and identity verification, these systems enhance convenience for patients while ensuring regulatory compliance and controlled access.

Healthcare providers and retail pharmacies are increasingly deploying these kiosks to expand service reach without incurring full operational costs associated with brick-and-mortar expansions. As telehealth adoption accelerates, automated kiosks are becoming critical touchpoints that bridge virtual consultations with physical medication fulfillment. Their integration into electronic health record (EHR) systems enables seamless, point-of-care dispensing, improving medication adherence and reducing delays in treatment initiation.

How Are Technological Innovations Enhancing the Safety, Compliance, and Integration Capabilities of Drug Kiosks?

Modern automated drug kiosks are equipped with advanced safety protocols, biometric authentication, and real-time monitoring to ensure secure and compliant dispensing. Integration with pharmacy management software and cloud-based platforms allows pharmacists to remotely approve prescriptions, track inventory, and manage refill cycles. Video conferencing modules are also being added to facilitate on-demand pharmacist consultations, preserving patient-pharmacist interaction while maintaining kiosk autonomy.

Regulatory-aligned features such as tamper detection, temperature control, and audit-ready tracking are positioning kiosks as compliant solutions even for sensitive or controlled medications. Integration with insurance databases and e-prescription systems enables eligibility verification and copay processing directly at the kiosk. As interoperability with broader digital health ecosystems strengthens, these kiosks are evolving into smart, decentralized pharmacy nodes capable of supporting both outpatient and chronic care workflows.

Where Is Adoption of Automated Drug Kiosks Accelerating and What Use Cases Are Driving Growth?

Adoption is gaining momentum in healthcare systems facing resource constraints, particularly in rural and underserved areas where pharmacy access is limited. Hospitals and urgent care centers are implementing kiosks to provide post-discharge or after-hours medication access, reducing readmission risks and improving continuity of care. Retail pharmacy chains are piloting kiosks in high-traffic public spaces-such as malls, airports, and campuses-to offer instant access to common medications and wellness products.

Government healthcare programs and humanitarian organizations are exploring kiosk deployments as part of public health outreach in remote and low-income regions. Additionally, large employers and universities are adopting these systems within wellness centers to streamline workforce health management. Use cases are also expanding into correctional facilities, senior living communities, and military bases-where controlled, trackable, and efficient dispensing is essential.

What Is Fueling the Global Expansion of the Automated Drug Kiosks Market?

Market growth is being driven by rising healthcare consumerism, cost-containment pressures, and digital transformation mandates across pharmacy services. Patients increasingly demand convenience, privacy, and 24/7 access, which kiosks can deliver at a fraction of traditional dispensing costs. The pandemic-era shift toward contactless service models further validated the role of automated dispensing in enhancing resilience and accessibility in pharmaceutical care.

Pharmacy chains, health systems, and medtech companies are forming partnerships to scale deployment and standardize integration with existing clinical and pharmacy workflows. Regulatory bodies are gradually updating guidelines to accommodate remote dispensing models, encouraging broader acceptance. As healthcare becomes more decentralized and patient-centric, a core question gains urgency: Can automated drug kiosks become the backbone of last-mile medication delivery in a system striving for greater equity, efficiency, and adherence?

SCOPE OF STUDY:

The report analyzes the Automated Drug Kiosks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Systems, Services); Drug Type (Prescriptions, Over-The-Counters, Other Drug Types); End-Use (Retail Pharmacies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Asteres Inc.
  • Bell and Howell
  • BestKiosk
  • Capsa Healthcare
  • Diebold Nixdorf
  • Distributed Delivery Networks Corp.
  • Higi
  • Howell LLC
  • ImageHOLDERS
  • Jadak
  • MC HealthGrid Pvt Ltd.
  • MedAvail Technologies Inc.
  • MedfriendRx
  • Omnicell Inc.
  • PharmcoRx
  • PickPoint
  • Rowa Automatisierungssysteme GmbH
  • ScriptPro LLC
  • Smart RX Systems Inc.
  • Stericycle Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Automated Drug Kiosks - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • 24/7 Dispensing Capability Positions Automated Drug Kiosks as a Pillar of Healthcare Accessibility
    • Integration With e-Prescriptions and EMRs Streamlines Pharmacy Workflow Through Drug Kiosks
    • Retail and Rural Healthcare Expansion Drives Adoption of Automated Drug Dispensing Kiosks
    • Pandemic-Era Contactless Health Trends Accelerate Public Acceptance of Automated Drug Kiosks
    • Regulatory Support for Remote Pharmaceutical Dispensing Enhances Legitimacy of Drug Kiosks
    • Insurance and Reimbursement Integration Improves Affordability of Medications Via Drug Kiosks
    • Compact Footprint and Low Operational Costs Make Automated Drug Kiosks Attractive to Pharmacies
    • AI-Enabled Inventory Management Increases Efficiency and Reduces Stockouts in Drug Kiosks
    • Deployment in Transit Hubs and Workplaces Expands Reach of Automated Drug Kiosk Services
    • Real-Time Access to High-Demand Medications Improves Chronic Disease Adherence Rates
    • Integration With Telepharmacy Platforms Expands Scope of Services Delivered Via Drug Kiosks
    • Automated Drug Kiosks Play a Strategic Role in Decentralizing Healthcare Distribution Networks
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Drug Kiosks Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Prescriptions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Prescriptions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Over-The-Counters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Over-The-Counters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION